Stefan K.F. Schwabe
2017
In 2017, Stefan K.F. Schwabe earned a total compensation of $1.2M as Executive Vice President of Research and Development, Chief Medical Officer at Supernus Pharmaceuticals, a 3% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $159,000 |
|---|---|
| Option Awards | $679,776 |
| Salary | $377,542 |
| Other | $31,606 |
| Total | $1,247,924 |
Schwabe received $679.8K in option awards, accounting for 54% of the total pay in 2017.
Schwabe also received $159K in non-equity incentive plan, $377.5K in salary and $31.6K in other compensation.
Rankings
In 2017, Stefan K.F. Schwabe's compensation ranked 7,917th out of 14,666 executives tracked by ExecPay. In other words, Schwabe earned more than 46.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,917 out of 14,666 | 46th |
Division Manufacturing | 2,967 out of 5,768 | 49th |
Major group Chemicals And Allied Products | 969 out of 2,074 | 53rd |
Industry group Drugs | 755 out of 1,730 | 56th |
Industry Pharmaceutical Preparations | 592 out of 1,329 | 56th |
Source: SEC filing on April 27, 2018.
Schwabe's colleagues
We found five more compensation records of executives who worked with Stefan K.F. Schwabe at Supernus Pharmaceuticals in 2017.
2017
Jack Khattar
Supernus Pharmaceuticals
Chief Executive Officer
2017
Victor Vaughn
Supernus Pharmaceuticals
Senior Vice President of Sales and Marketing
2017
Gregory Patrick
Supernus Pharmaceuticals
Chief Financial Officer
2017
Padmanabh Bhatt
Supernus Pharmaceuticals
Chief Scientific Officer
2017
Tami RN
Supernus Pharmaceuticals